BamSEC and AlphaSense Join Forces
Learn More

Phage Biotechnology CORP

Material Contracts Filter

EX-10.13
from 10-12G/A 5 pages December 18th 1998 Confidential • a Transaction Fee Equal to 15% of Aggregate Gross Proceeds Received or to Be Received by the Company From the Sale of Securities in Any Transaction During the Term. • at Present No Warrants Will Be Issued by the Company for the Benefit of Ghl
12/34/56
EX-10.12
from 10-12G/A 3 pages Inter-Company Related Items Policy
12/34/56
EX-10.11
from 10-12G/A 2 pages Service Agreement
12/34/56
EX-10.10
from 10-12G/A 7 pages License Agreement
12/34/56
EX-10.9
from 10-12G 7 pages Participatory Interests Purchase Agreement
12/34/56
EX-10.8
from 10-12G 6 pages Confidential Material Transfer, and Limited Research License and Exclusivity Period, Agreement
12/34/56
EX-10.7
from 10-12G 36 pages Lease (Multi-Tenant; Net; “As Is”) Between the Irvine Company and Phage Biotechnology Corporation Index to Lease
12/34/56
EX-10.6(B)
from 10-12G 38 pages Industrial Lease (Multi-Tenant; Net) Between the Irvine Company and the Regents of the University of California (101 Theory, Suite 200, Irvine, California) Index to Lease
12/34/56
EX-10.6(A)
from 10-12G 11 pages Sublease Agreement Between the Regents of the University of California and Phage Biotechnology Corporation August 24, 2004 Sublease Agreement
12/34/56
EX-10.5
from 10-12G 6 pages Development Agreement Between Biopolymed, Inc. and Phage Biotechnology, Inc
12/34/56
EX-10.4
from 10-12G 8 pages Master Agreement by and Between Mpi Research, Inc. (Hereinafter Referred to as Mfl) Mattawan, Michigan and Phage Biotechnology Corporation (Hereinafter Referred to as the Sponsor) Tustin, California
12/34/56
EX-10.3
from 10-12G 7 pages Services Agreement
12/34/56
EX-10.2
from 10-12G 11 pages Distributorship Agreement
12/34/56
EX-10.1
from 10-12G 8 pages Joint Patent Ownership and License Agreement
12/34/56